SEPT9_i1 is required for the association between HIF-1α and importin-α to promote efficient nuclear translocation

References

• Spiliotis ET, Gladfelter AS. Spatial guidance of cell asymmetry: septin GTPases show the way. Traffic 2012; 13:195 - 203; http://dx.doi.org/10.1111/j.1600-0854.2011.01268.x; PMID: 21883761
   PubMed Web of Science ®Google Scholar
• Connolly D, Yang Z, Castaldi M, Simmons N, Oktay MH, Coniglio S, et al. Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression. Breast Cancer Res 2011; 13:R76; http://dx.doi.org/10.1186/bcr2924; PMID: 21831286
   PubMed Web of Science ®Google Scholar
• Gonzalez ME, Peterson EA, Privette LM, Loffreda-Wren JL, Kalikin LM, Petty EM. High SEPT9_v1 expression in human breast cancer cells is associated with oncogenic phenotypes. Cancer Res 2007; 67:8554 - 64; http://dx.doi.org/10.1158/0008-5472.CAN-07-1474; PMID: 17875694
   PubMed Web of Science ®Google Scholar
• Montagna C, Lyu MS, Hunter K, Lukes L, Lowther W, Reppert T, et al. The Septin 9 (MSF) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines. Cancer Res 2003; 63:2179 - 87; PMID: 12727837
   PubMed Web of Science ®Google Scholar
• Burrows JF, Chanduloy S, McIlhatton MA, Nagar H, Yeates K, Donaghy P, et al. Altered expression of the septin gene, SEPT9, in ovarian neoplasia. J Pathol 2003; 201:581 - 8; http://dx.doi.org/10.1002/path.1484; PMID: 14648661
   PubMed Web of Science ®Google Scholar
• Scott M, McCluggage WG, Hillan KJ, Hall PA, Russell SE. Altered patterns of transcription of the septin gene, SEPT9, in ovarian tumorigenesis. Int J Cancer 2006; 118:1325 - 9; http://dx.doi.org/10.1002/ijc.21486; PMID: 16161048
   PubMed Web of Science ®Google Scholar
• Bennett KL, Karpenko M, Lin MT, Claus R, Arab K, Dyckhoff G, et al. Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma. Cancer Res 2008; 68:4494 - 9; http://dx.doi.org/10.1158/0008-5472.CAN-07-6509; PMID: 18559491
   PubMed Web of Science ®Google Scholar
• Stanbery L, D’Silva NJ, Lee JS, Bradford CR, Carey TE, Prince ME, et al. High SEPT9_v1 Expression Is Associated with Poor Clinical Outcomes in Head and Neck Squamous Cell Carcinoma. Transl Oncol 2010; 3:239 - 45; PMID: 20689765
   PubMed Web of Science ®Google Scholar
• Amir S, Wang R, Matzkin H, Simons JW, Mabjeesh NJ. MSF-A interacts with hypoxia-inducible factor-1alpha and augments hypoxia-inducible factor transcriptional activation to affect tumorigenicity and angiogenesis. Cancer Res 2006; 66:856 - 66; http://dx.doi.org/10.1158/0008-5472.CAN-05-2738; PMID: 16424018
   PubMed Web of Science ®Google Scholar
• Podar K, Anderson KC. A therapeutic role for targeting c-Myc/Hif-1-dependent signaling pathways. Cell Cycle 2010; 9:1722 - 8; http://dx.doi.org/10.4161/cc.9.9.11358; PMID: 20404562
   PubMed Web of Science ®Google Scholar
• Cosse JP, Michiels C. Tumor hypoxia affects the responsiveness of cancer cells to chemotherapy and promotes cancer progression. Anticancer Agents Med Chem 2008; 8:790 - 7; http://dx.doi.org/10.2174/187152008785914798; PMID: 18855580
   PubMed Web of Science ®Google Scholar
• Semenza GL. Hypoxia and cancer. Cancer Metastasis Rev 2007; 26:223 - 4; http://dx.doi.org/10.1007/s10555-007-9058-y; PMID: 17404692
   PubMed Web of Science ®Google Scholar
• Semenza GL. Hypoxia and human disease-and the Journal of Molecular Medicine. J Mol Med (Berl) 2007; 85:1293 - 4; http://dx.doi.org/10.1007/s00109-007-0285-z; PMID: 18026915
   PubMed Web of Science ®Google Scholar
• Park EJ, Kong D, Fisher R, Cardellina J, Shoemaker RH, Melillo G. Targeting the PAS-A domain of HIF-1alpha for development of small molecule inhibitors of HIF-1. Cell Cycle 2006; 5:1847 - 53; http://dx.doi.org/10.4161/cc.5.16.3019; PMID: 16861921
   PubMed Web of Science ®Google Scholar
• Gardner LB, Corn PG. Hypoxic regulation of mRNA expression. Cell Cycle 2008; 7:1916 - 24; http://dx.doi.org/10.4161/cc.7.13.6203; PMID: 18604161
   PubMed Web of Science ®Google Scholar
• Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 2010; 29:625 - 34; http://dx.doi.org/10.1038/onc.2009.441; PMID: 19946328
   PubMed Web of Science ®Google Scholar
• Wilson IA, Haft DH, Getzoff ED, Tainer JA, Lerner RA, Brenner S. Identical short peptide sequences in unrelated proteins can have different conformations: a testing ground for theories of immune recognition. Proc Natl Acad Sci U S A 1985; 82:5255 - 9; http://dx.doi.org/10.1073/pnas.82.16.5255; PMID: 2410917
   PubMed Web of Science ®Google Scholar
• Depping R, Steinhoff A, Schindler SG, Friedrich B, Fagerlund R, Metzen E, et al. Nuclear translocation of hypoxia-inducible factors (HIFs): involvement of the classical importin alpha/beta pathway. Biochim Biophys Acta 2008; 1783:394 - 404; http://dx.doi.org/10.1016/j.bbamcr.2007.12.006; PMID: 18187047
   PubMed Web of Science ®Google Scholar
• Amir S, Golan M, Mabjeesh NJ. Targeted knockdown of SEPT9_v1 inhibits tumor growth and angiogenesis of human prostate cancer cells concomitant with disruption of hypoxia-inducible factor-1 pathway. Mol Cancer Res 2010; 8:643 - 52; http://dx.doi.org/10.1158/1541-7786.MCR-09-0497; PMID: 20407014
   PubMed Web of Science ®Google Scholar
• Amir S, Wang R, Simons JW, Mabjeesh NJ. SEPT9_v1 up-regulates hypoxia-inducible factor 1 by preventing its RACK1-mediated degradation. J Biol Chem 2009; 284:11142 - 51; http://dx.doi.org/10.1074/jbc.M808348200; PMID: 19251694
   PubMed Web of Science ®Google Scholar
• Sellin ME, Stenmark S, Gullberg M. Mammalian SEPT9 isoforms direct microtubule-dependent arrangements of septin core heteromers. Mol Biol Cell 2012; 23:4242 - 55; http://dx.doi.org/10.1091/mbc.E12-06-0486; PMID: 22956766
   PubMed Web of Science ®Google Scholar
• Kinoshita M. Assembly of mammalian septins. J Biochem 2003; 134:491 - 6; http://dx.doi.org/10.1093/jb/mvg182; PMID: 14607974
   PubMed Web of Science ®Google Scholar
• Luo JC, Shibuya M. A variant of nuclear localization signal of bipartite-type is required for the nuclear translocation of hypoxia inducible factors (1alpha, 2alpha and 3alpha). Oncogene 2001; 20:1435 - 44; http://dx.doi.org/10.1038/sj.onc.1204228; PMID: 11313887
   PubMed Web of Science ®Google Scholar
• Chachami G, Paraskeva E, Mingot JM, Braliou GG, Görlich D, Simos G. Transport of hypoxia-inducible factor HIF-1alpha into the nucleus involves importins 4 and 7. Biochem Biophys Res Commun 2009; 390:235 - 40; http://dx.doi.org/10.1016/j.bbrc.2009.09.093; PMID: 19788888
   PubMed Web of Science ®Google Scholar
• Manisterski M, Golan M, Amir S, Weisman Y, Mabjeesh NJ. Hypoxia induces PTHrP gene transcription in human cancer cells through the HIF-2α. Cell Cycle 2010; 9:3723 - 9; http://dx.doi.org/10.4161/cc.9.18.12931; PMID: 20890122
   PubMed Web of Science ®Google Scholar
• Mabjeesh NJ, Escuin D, LaVallee TM, Pribluda VS, Swartz GM, Johnson MS, et al. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 2003; 3:363 - 75; http://dx.doi.org/10.1016/S1535-6108(03)00077-1; PMID: 12726862
   PubMed Web of Science ®Google Scholar
• Mabjeesh NJ, Post DE, Willard MT, Kaur B, Van Meir EG, Simons JW, et al. Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells. Cancer Res 2002; 62:2478 - 82; PMID: 11980636
   PubMed Web of Science ®Google Scholar
• Ben-Shoshan M, Amir S, Dang DT, Dang LH, Weisman Y, Mabjeesh NJ. 1alpha,25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells. Mol Cancer Ther 2007; 6:1433 - 9; http://dx.doi.org/10.1158/1535-7163.MCT-06-0677; PMID: 17431122
   PubMed Web of Science ®Google Scholar